Abattis Bioceuticals (Abattis Bioceuticals) EV-to-EBITDA : 0.00 (As of Jun. 07, 2024)

Abattis Bioceuticals EV-to-EBITDA Chart

Abattis Bioceuticals Annual Data
	Trend	Sep10	Sep11	Sep12	Sep13	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19
EV-to-EBITDA		Get a 7-Day Free Trial					-0.55	-3.32	-3.62	-0.86	-12.74

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
EV-to-EBITDA	Get a 7-Day Free Trial															-0.86	-0.46	-0.57	-0.67	-12.74

Competitive Comparison of Abattis Bioceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's EV-to-EBITDA falls into.

Abattis Bioceuticals EV-to-EBITDA Calculation

Abattis Bioceuticals's EV-to-EBITDA for today is calculated as:

Abattis Bioceuticals's current Enterprise Value is $0.00 Mil.
Abattis Bioceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abattis Bioceuticals  (OTCPK:ATTBF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Abattis Bioceuticals's PE Ratio for today is calculated as:

Abattis Bioceuticals's share price for today is $0.0001.
Abattis Bioceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Abattis Bioceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description